SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
小蘑菇
Lv4
520 积分
2024-12-16 加入
最近求助
最近应助
互助留言
Antiandrogens in Prostate Cancer
1天前
已完结
'Acute on chronic' effect of depot leuprolide in patients with stage D2 cancer of prostate
8天前
已完结
IL-17A, IL-22, and IL-23 as Markers of Psoriasis Activity
1个月前
已完结
An Innovative Approach to Optimize First‐In‐Human Minimal Anticipated Biological Effect Level Based Starting Dose in Oncology Trials for Bispecific T‐Cell Engagers: Experience from A Solid Tumor Bispecific T‐Cell Engager
1个月前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
1个月前
已完结
First‐in‐Human Dose Selection for T‐Cell Engaging Bispecific Antibodies
1个月前
已完结
An Integrated Multiple-Analyte Pharmacokinetic Model to Characterize Trastuzumab Emtansine (T-DM1) Clearance Pathways and to Evaluate Reduced Pharmacokinetic Sampling in Patients with HER2-Positive Metastatic Breast Cancer
2个月前
已完结
Clinical Implications of Pathophysiological and Demographic Covariates on the Population Pharmacokinetics of Trastuzumab Emtansine, a HER2‐Targeted Antibody‐Drug Conjugate, in Patients With HER2‐Positive Metastatic Breast Cancer
2个月前
已完结
Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development
2个月前
已完结
Translational PK/PD framework for antibody-drug conjugates to inform drug discovery and development
2个月前
已完结
没有进行任何应助
点赞,帮大忙了,么么哒
2个月前
点赞,速度真快
2个月前
速度真快
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论